Canada markets open in 8 hours 28 minutes

GILD Feb 2023 45.000 put

OPR - OPR Delayed Price. Currency in USD
Add to watchlist
0.04000.0000 (0.00%)
As of 09:30AM EST. Market open.
Full screen
Loading interactive chart...
  • Motley Fool

    Gilead Sciences (GILD) Q4 2022 Earnings Call Transcript

    Thank you for attending today's fourth quarter and full year 2022 Gilead Sciences earnings conference call. Just after market closed today, we issued a press release with earnings results for the fourth quarter and full year 2022. The speakers on today's call will be our chairman and chief executive officer, Daniel O'Day; our chief commercial officer, Johanna Mercier; our chief medical officer, Merdad Parsey; and our chief financial officer, Andrew Dickinson.

  • Zacks

    Gilead Sciences (GILD) Tops Q4 Earnings and Revenue Estimates

    Gilead (GILD) delivered earnings and revenue surprises of 11.33% and 12.24%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?

  • Business Wire

    Gilead Sciences Announces 2.7 Percent Increase in First Quarter 2023 Dividend

    FOSTER CITY, Calif., February 02, 2023--Gilead Sciences, Inc. (Nasdaq: GILD) today announced that the company’s Board of Directors has declared an increase of 2.7% in the company’s quarterly cash dividend, beginning in the first quarter of 2023. The increase will result in a quarterly dividend of $0.75 per share of common stock. The dividend is payable on March 30, 2023, to stockholders of record at the close of business on March 15, 2023. Future dividends will be subject to Board approval.